Difference between revisions of "Team:Newcastle/Attributions"

Line 284: Line 284:
 
             <div class="row section-header has-bottom-sep light-sep" data-aos="fade-up">
 
             <div class="row section-header has-bottom-sep light-sep" data-aos="fade-up">
 
                 <div class="col-full">
 
                 <div class="col-full">
                     <h3 class="subhead">Parts</h3>
+
                     <h3 class="subhead">Acknowledgements</h3>
                     <h1 class="display-2 display-2--light">Check out what parts we're using</h1>
+
                     <h1 class="display-2 display-2--light">Additional Support</h1>
 
                     <font size="5" font face="verdana" font color="green">We will be utilising iGEM registry parts sequenced by IDT to construct a biosynthetic  
 
                     <font size="5" font face="verdana" font color="green">We will be utilising iGEM registry parts sequenced by IDT to construct a biosynthetic  
 
                     operon for expression in Escherichia coli. The operon will synthesise naringenin, a flavonoid that attracts nitrogen fixing bacteria.  
 
                     operon for expression in Escherichia coli. The operon will synthesise naringenin, a flavonoid that attracts nitrogen fixing bacteria.  

Revision as of 09:35, 4 September 2018

Menu
Alternative Roots/Attributions

Alternative Roots

Attributions and
Acknowledgements

2018 Newcastle iGEM

Attributions

Initial Project Idea

  • Lewis Tomlinson
  • Connor Trotter
  • Chris Carty
  • Frank Eardley
  • Heather Bottomley
  • Luke Waller
  • Patrycja Ubysz
  • Umar Farooq
  • Will Tankard
  • Sadiya Quazi

Project Support

  • Dr. Thomas Howard
  • Dr. Jon Marles-Wright
  • Dr. Jem Stach
  • Dr. Alice Banks
  • Dr. Colette Whitfield
  • Jasmine Bird
  • Alba Iglesias-Vilches
  • Dr. Maxim Kapralov
  • Dr. Maria Del Carmen Montero-Calasanz
  • Dr. Vasilios Andriotis

Chemotaxis

  • Connor Trotter
  • Sadiya Quazi
  • Lewis Tomlinson
  • Frank Eardley
  • Dr. Alice Banks

Endophyte Development

  • Lewis Tomlinson
  • Frank Eardley
  • Dr. Maria Del Carmen Montero-Calasanz

Operon Development

  • Heather Bottomley
  • Patrycja Ubysz

Hardware

  • Luke Waller
  • Umar Farooq
  • Chris Carty
  • Lewis Tomlinson

Software

  • Umar Farooq
  • Luke Waller
  • Frank Eardley
  • Matthew Burridge

Wiki Design

  • Umar Farooq
  • Will Tankard
  • Bradley Brown

Community Modelling

  • Patrycja Ubysz
  • Dr. Dana Ofiteru

Biosynthesis Pathway Modelling

  • Frank Eardley
  • Luke Waller
  • Umar Farooq
  • Josh Isaac
  • Aidan Clamp

Human Practices

  • Will Tankard
  • Chris Carty
  • Umar Farooq
  • Lewis Tomlinson
  • Luke Waller
  • Dr. Martyn Dade-Robertson

Outreach and Engagement

  • Heather Bottomley
  • Will Tankard

Interlab Study

  • Matthew Burridge
  • Kyle Stanforth
  • Sam Went

Acknowledgements

Additional Support

We will be utilising iGEM registry parts sequenced by IDT to construct a biosynthetic operon for expression in Escherichia coli. The operon will synthesise naringenin, a flavonoid that attracts nitrogen fixing bacteria. The operon will contain the genes for four enzymes: 4 – Coumaryl ligase – 4CL (BBa_K1033001), Tyrosine ammonia lyase - TAL (BBa_K1033000), Chalcone isomerase - CHI (BBa_K1497000) and Chalcone synthase - CHS (BBa_K1497001). Each of these parts contain a strong ribosome binding site (BBa_B0034). This construct will be under the control of a T7 promoter (BBa_I712074) to observe its expression in E. coli as a proof of concept. Once biosynthesis under the control of T7 is achieved, the construct will be tested under a constitutive promoter (BBa_J23100). Parts for biosynthesis in the final chassis organism, root-colonising Pseudomonas fluorescens, will be constructed in the plasmid backbone pBSC1C3.